Guided Therapeutics, Inc. (OTCBB:GTHP) announced a private placement of a convertible debenture for gross proceeds of $1,130,000 on June 3, 2021. The note will have a term period of 3 years. The note carries fixed conversion price of $0.50 per note. The note will automatically convert into the shares in a subsequent financing if that financing is undertaken in connection with an uplisting to Nasdaq.